Literature DB >> 2299088

Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery.

H Wolinsky1, S N Thung.   

Abstract

A perforated catheter was used to deliver either horseradish peroxidase or fluoresceinated heparin under pressure to the canine arterial wall. Depth of penetration of the media by horseradish peroxidase was dependent on perfusion pressure. At 5 bar pressure for 1 min, the entire media showed a reaction product for horseradish peroxidase. Fluoresceinated heparin delivered under the same conditions could be demonstrated to traverse the entire media as well. A pressure of 5 bars caused medial necrosis at 48 h after perfusion, even when the perfusing solution was saline. (This did not differ from the effect of standard angioplasty at the same pressure.) However, heparin at 5,000 U/ml did not cause medial alteration at 48 h when delivered at the lower pressure of 500 mm Hg. It is feasible to deliver heparin over 1 min in high concentration to the arterial wall by means of this balloon catheter. This method may permit the use of commercially prepared heparin in high concentration as an antiproliferative agent to control the problem of restenosis after angioplasty.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299088     DOI: 10.1016/s0735-1097(10)80079-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

Review 2.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 3.  [Local drug delivery and gene therapy].

Authors:  H Darius; M Buerke; J P Boissel; T Grosser; K Veit; K Zacharowski; J Meyer
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

4.  Induction of thrombolysis and prevention of thrombus formation by local drug delivery with a double-occlusion balloon catheter.

Authors:  T Tomaru; Y Fujimori; F Nakamura; N Aoki; Y Sakamoto; K Kawai; M Omata; Y Uchida
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

5.  Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries.

Authors:  T Tomaru; F Nakamura; N Aoki; Y Sakamoto; M Omata; Y Uchida
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

Review 6.  Gene delivery technologies for cardiac applications.

Authors:  M G Katz; A S Fargnoli; L A Pritchette; C R Bridges
Journal:  Gene Ther       Date:  2012-03-15       Impact factor: 5.250

7.  Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy.

Authors:  Ulrich Westedt; Lucian Barbu-Tudoran; Andreas K Schaper; Marc Kalinowski; Heiko Alfke; Thomas Kissel
Journal:  AAPS PharmSci       Date:  2002

Review 8.  Coronary restenosis and gene therapy.

Authors:  W Mazur; N M Ali; A E Raizner; B A French
Journal:  Tex Heart Inst J       Date:  1994

Review 9.  Pharmacological approaches to the prevention of restenosis after coronary angioplasty.

Authors:  M Hamon; E Lécluse; J P Monassier; G Grollier; J C Potier
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

Review 10.  Cardiovascular gene therapy: current status and therapeutic potential.

Authors:  M M Gaffney; S O Hynes; F Barry; T O'Brien
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.